Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
"As the obesity drug market is expected to continue expanding, Korean companies should actively capitalize on these changing consumer trends as a new growth opportunity," said Lee Jong-woo, a professor of distribution and marketing at Namseoul University
Recent analyses comparing GLP-1 medications to bariatric surgery have found surgery to offer better value in certain populations, despite its invasive nature
Managing health while living with the chronic disease of obesity often includes a combination of medical treatment, including medications and surgical options, along with nutrition, physical activity, mental and emotional well-being and ongoing support
Drugs like Ozempic and Wegovy have had a meteoric rise in recent years, with benefits like weight loss and help with other health issues
US$ 23.17
US$ 26.15
US$ 20.68
